Methods for modulating the human sexual response

Details Methods for modulating the human sexual response Methods for modulating the human sexual response

1994-08-09

1996-10-15

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514644, 514471, 514649, 514400, 514396, 514307, 514509, 514532, 514523, 514212, A61K 3144

Patent

active

055654665

ABSTRACT:
The invention is directed to improved methods for modulating the human sexual response by administering a vasodilator to the circulation by a route of administration that avoids the "first-pass" effect.

REFERENCES:
patent: 3943246 (1976-03-01), Sturmer
patent: 4127118 (1978-11-01), Latorre
patent: 4139617 (1979-02-01), Grunwell et al.
patent: 4530920 (1985-07-01), Nestor et al.
patent: 4801587 (1989-01-01), Voss et al.
patent: 4863911 (1989-09-01), Anderson, Jr. et al.
patent: 4885173 (1989-12-01), Stanley et al.
patent: 5059603 (1991-10-01), Rubin
patent: 5065744 (1991-11-01), Zusmanovsky
patent: 5145852 (1992-09-01), Virag
patent: 5236904 (1993-08-01), Gerstenberg et al.
patent: 5256652 (1993-10-01), El-Rashidy
patent: 5270323 (1993-12-01), Milne, Jr. et al.
patent: 5399581 (1995-03-01), Laragh et al.
Althof, S. E. et al., Sexual, psychological, and marital impact of self-injection of papaverine and phentolamine; a long-term prospective study, J. Sex & Marital Ther., 17(2):101-112 (1991).
Azadzoi, K. M. et al., Effects of Intracavernosal Trazadone Hydrochloride; Animal and Human Studies, J. Urol., 144(5):1277-1282 (1990).
Brindley, G. S., Cavernosal Alpha-Blockade: A New Technique for Investigating and treating Erectile Impotence, Brit. J. Psychiat., 143:332-337 (1983).
Brindley, G. S., Cavernosal alpha-blockade and human penile erection, J. Physiol., 342:24P (1983).
Brindley, G. S., Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis, Br. J. Pharmac. 87: 495-500 (1986).
Corriere, Jr. et al., Development of Fibrotic Penile Lesions Secondary to the Intracorporeal Injection of Vasoactive Agents, J. Urol., 140:615-617 (1988).
Gwinup, G., Oral Phentolamine in Nonspecific Erectile Insufficiency, Ann. Int. Med., 15 Jul. 1988, 162-163.
Larsen, E. H. et al., Fibrosis of Corpus Cavernosum after Intracavernous Injection of Phentolamine/Papaverine, J. Urol., 137:292-293 (1987).
Sonda, L. P. et al., The Role of Yohimbine for the Treatment of Erectile Impotence, J. Sex & Marital Ther., 16(1):15-21 (1990).
Virag, R., Intracavernous Injection of Papaverine for Erectile Failure, Lancet, ii:938 (1984).
Virag, R. et al., Intracavernous Injection of Papaverine as a Diagnostic and Therapeutic Method in Erectile Failure, Angiology, 35:79-87 (1984).
Zorgniotti, A. W. et al., Auto-Injection of the Corpus Cavernosum with a Vasoactive Drug Combination for Vasculogenic Impotence, J. Urol., 133:39-41 (1985).

Affiliated with

Also associated with

Rating

Methods for modulating the human sexual response does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for modulating the human sexual response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for modulating the human sexual response will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1246387